EP2714036
Útskiptir (súbstitúeraðir) alífanar, sýklófanar, heterafanar, heterófanar, heteró-heterafanar og metallósenar sem nýtast við meðferð á HCV sýkingum
:
EP Einkaleyfi fallið úr gildi:
29.5.2012:
22.6.2016:
12793566.6
:
25.7.2016:
15.8.2016
:
28.5.2032:
28.5.2019
:
SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS
29.5.2012
22.6.2016
25.7.2016
15.8.2016
28.5.2019
:
Achillion Pharmaceuticals, Inc.:
300 George Street, 06511, New Haven, US
:
WILES, Jason Allan:
Hamden, CT, US
:
WANG, Qiuping:
Bethany, CT, US
:
HASHIMOTO, Akihiro:
Branford, CT, US
:
PAIS, Godwin:
Hamden, CT, US
:
CHEN, Dawei:
Middletown, CT, US
:
WANG, Xiangzhu:
Madison CT, US
:
GADHACHANDA, Venkat:
Hamden, CT, US
:
PHADKE, Avinash:
Branford, CT, US
:
DESHPANDE, Milind:
Madison, CT, US
:
Novagraaf Brevets:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
:
201161490881 P:
27.5.2011:
US
:
201161504905 P:
6.7.2011:
US
:
201161567216 P:
6.12.2011:
US
:
WO2012166716:
29.5.2012
:
C07F 17/02, C07D 401/14, C07D 403/14, C07D 413/14, C07D 417/14, C07D 471/08, C07D 471/14, C07D 491/10, C07D 519/00, A61K 31/4178, A61K 31/4164, A61P 31/00, A61P 31/12
: 6
: 10.4.2017
: 28.5.2018
: Árnason Faktor
: 7
: 14.5.2018
: 28.5.2019
: Árnason Faktor